|
As a public company, Nutra Pharma Corporation (including its subsidiaries or affiliates that it
controls or is under common control with (the “Company”) has an obligation to its shareholders
to ensure that all material information disseminated to the public is factual, accurate, and in
compliance with all applicable state and federal securities laws, including Regulation Fair
Disclosure (“Reg FD”), state and federal anti-fraud and anti-manipulation rules and securities
laws applicable to insider trading.
In September 2010, Nutra Pharma's board of directors adopted the following Corporate Communications Policy:
 Download
PDF (111kb)
|
